Keywords: Bayer, First-quarter 2011 financial results
Bayer sales rise 13% in 1st-qtr 2011, but pharma sales to stay flat this year
Article | 28 April 2011
German pharma, crop sciences and chemicals group Bayer (BAY: DE) posted a solid set of first-quarter 2011 results, with sales up 13.2% ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
